Compton Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,750
| Closed | -$248K | – | 19 |
|
|
2023
Q1 | $248K | Sell |
1,750
-3,150
| -64% | -$451K | 0.53% | 41 |
|
|
2022
Q4 | $767K | Sell |
4,900
-900
| -16% | -$129K | 0.55% | 43 |
|
|
2022
Q3 | $712K | Sell |
5,800
-1,350
| -19% | -$178K | 0.48% | 44 |
|
|
2022
Q2 | $951K | Sell |
7,150
-3,400
| -32% | -$463K | 0.52% | 43 |
|
|
2022
Q1 | $1.44M | Sell |
10,550
-300
| -3% | -$41.8K | 0.4% | 60 |
|
|
2021
Q4 | $1.88M | Sell |
10,850
-550
| -5% | -$83.7K | 0.49% | 51 |
|
|
2021
Q3 | $1.66M | Buy |
11,400
+7,500
| +192% | +$1.1M | 0.49% | 51 |
|
|
2021
Q2 | $515K | Sell |
3,900
-200
| -5% | -$26.2K | 0.15% | 107 |
|
|
2021
Q1 | $526K | Hold |
4,100
| – | – | 0.16% | 104 |
|
|
2020
Q4 | $489K | Hold |
4,100
| – | – | 0.17% | 95 |
|
|
2020
Q3 | $469K | Hold |
4,100
| – | – | 0.18% | 88 |
|
|
2020
Q2 | $467K | Sell |
4,100
-50
| -1% | -$5.3K | 0.2% | 83 |
|
|
2020
Q1 | $333K | Hold |
4,150
| – | – | 0.16% | 89 |
|
|
2019
Q4 | $443K | Hold |
4,150
| – | – | 0.17% | 93 |
|
|
2019
Q3 | $444K | Hold |
4,150
| – | – | 0.19% | 94 |
|
|
2019
Q2 | $423K | Sell |
4,150
-300
| -7% | -$28.8K | 0.18% | 100 |
|
|
2019
Q1 | $400K | Hold |
4,450
| – | – | 0.17% | 101 |
|
|
2018
Q4 | $371K | Hold |
4,450
| – | – | 0.18% | 104 |
|
|
2018
Q3 | $480K | Sell |
4,450
-100
| -2% | -$11K | 0.19% | 101 |
|
|
2018
Q2 | $500K | Hold |
4,550
| – | – | 0.21% | 99 |
|
|
2018
Q1 | $456K | Sell |
4,550
-50
| -1% | -$5.12K | 0.19% | 105 |
|
|
2017
Q4 | $453K | Hold |
4,600
| – | – | 0.19% | 105 |
|
|
2017
Q3 | $431K | Sell |
4,600
-200
| -4% | -$21.2K | 0.19% | 104 |
|
|
2017
Q2 | $534K | Hold |
4,800
| – | – | 0.24% | 96 |
|
|
2017
Q1 | $471K | Hold |
4,800
| – | – | 0.23% | 94 |
|
|
2016
Q4 | $441K | Sell |
4,800
-5,000
| -51% | -$431K | 0.23% | 93 |
|
|
2016
Q3 | $814K | Buy |
9,800
+4,900
| +100% | +$412K | 0.23% | 93 |
|
|
2016
Q2 | $399K | Sell |
4,900
-200
| -4% | -$15.2K | 0.22% | 96 |
|
|
2016
Q1 | $364K | Sell |
5,100
-100
| -2% | -$6.71K | 0.2% | 96 |
|
|
2015
Q4 | $370K | Hold |
5,200
| – | – | 0.21% | 95 |
|
|
2015
Q3 | $320K | Sell |
5,200
-200
| -4% | -$14K | 0.12% | 98 |
|
|
2015
Q2 | $392K | Sell |
5,400
-100
| -2% | -$7.38K | 0.22% | 96 |
|
|
2015
Q1 | $423K | Hold |
5,500
| – | – | 0.24% | 88 |
|
|
2014
Q4 | $369K | Hold |
5,500
| – | – | 0.2% | 101 |
|
|
2014
Q3 | $334K | Sell |
5,500
-200
| -4% | -$12.3K | 0.18% | 109 |
|
|
2014
Q2 | $335K | Hold |
5,700
| – | – | 0.18% | 110 |
|
|
2014
Q1 | $330K | Buy |
5,700
+200
| +4% | +$10.7K | 0.19% | 106 |
|
|
2013
Q4 | $294K | Hold |
5,500
| – | – | 0.17% | 110 |
|
|
2013
Q3 | $340K | Sell |
5,500
-400
| -7% | -$23.9K | 0.21% | 103 |
|
|
2013
Q2 | $358K | Buy |
+5,900
| New | +$351K | 0.22% | 99 |
|
Other funds holding DGX
Compton Capital Management's DGX Position: Q2 2023 in Review
Compton Capital Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 1,750 shares — an estimated $248K sold.
Compton Capital Management first reported a position in DGX in Q2 2013 and held it in 40 quarters. The position peaked at $1.88M in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Compton Capital Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Compton Capital Management sold 1,750 Quest Diagnostics shares in Q2 2023, an estimated $248K.
- Compton Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 40 quarters.
- Compton Capital Management's Quest Diagnostics position peaked at $1.88M in Q4 2021.
- 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Compton Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.